Ameritas Investment Partners
TSHA icon

Ameritas Investment Partners’s Taysha Gene Therapies TSHA Stock Holding History

Ameritas Investment Partners’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Buy
21,761
+4,089
+23% +$24.2K ﹤0.01% 1593
2026
Q1 		$79K Hold
17,672
– – ﹤0.01% 1830
2025
Q4 		$97.2K Buy
17,672
+2,000
+13% +$9.71K ﹤0.01% 1717
2025
Q3 		$51.2K Hold
15,672
– – ﹤0.01% 2101
2025
Q2 		$36.2K Hold
15,672
– – ﹤0.01% 2376
2025
Q1 		$21.8K Hold
15,672
– – ﹤0.01% 2517
2024
Q4 		$27.1K Hold
15,672
– – ﹤0.01% 2501
2024
Q3 		$31.5K Hold
15,672
– – ﹤0.01% 2432
2024
Q2 		$35.1K Buy
+15,672
New +$45.6K ﹤0.01% 2333
2022
Q2 		– Sell
-1,745
Closed -$11K – 3235
2022
Q1 		$11K Hold
1,745
– – ﹤0.01% 2771
2021
Q4 		$20K Hold
1,745
– – ﹤0.01% 2656
2021
Q3 		$32K Hold
1,745
– – ﹤0.01% 2440
2021
Q2 		$37K Buy
1,745
+1,018
+140% +$23.5K ﹤0.01% 2390
2021
Q1 		$15K Hold
727
– – ﹤0.01% 2692
2020
Q4 		$19K Buy
+727
New +$15.7K ﹤0.01% 2504

Other funds holding TSHA

Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameritas Investment Partners's TSHA Position: Q2 2026 in Review

Ameritas Investment Partners increased its Taysha Gene Therapies (TSHA) stake by 23% in Q2 2026, buying an estimated $24.2K and bringing the position to 21,761 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1593.

Ameritas Investment Partners first reported a position in TSHA in Q4 2020 and has held it in 15 quarters since. 208 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Ameritas Investment Partners held 21,761 shares of Taysha Gene Therapies worth $148K as of Q2 2026.
  • Ameritas Investment Partners bought 4,089 Taysha Gene Therapies shares in Q2 2026, an estimated $24.2K.
  • Taysha Gene Therapies made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1593 holding.
  • Ameritas Investment Partners first reported a position in Taysha Gene Therapies in Q4 2020 and has held it in 15 quarters since.
  • 208 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.